Proteome Sciences plc (AIM:PRM)
2.134
+0.334 (18.56%)
Jul 27, 2026, 3:33 PM GMT
Proteome Sciences Revenue
In the year 2025, Proteome Sciences had annual revenue of 3.76M GBP, down -23.14%. Proteome Sciences had revenue of 1.90M in the half year ending December 31, 2025, with 4.46% growth.
Revenue
3.76M
Revenue Growth
-23.14%
P/S Ratio
1.77
Revenue / Employee
117.38K
Employees
32
Market Cap
6.66M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.76M | -1.13M | -23.14% |
| Dec 31, 2024 | 4.89M | -141.00K | -2.80% |
| Dec 31, 2023 | 5.03M | -2.75M | -35.37% |
| Dec 31, 2022 | 7.78M | 2.65M | 51.69% |
| Dec 31, 2021 | 5.13M | 376.00K | 7.91% |
| Dec 31, 2020 | 4.75M | 97.00K | 2.08% |
| Dec 31, 2019 | 4.66M | 1.61M | 52.71% |
| Dec 31, 2018 | 3.05M | -331.00K | -9.79% |
| Dec 31, 2017 | 3.38M | 636.00K | 23.18% |
| Dec 31, 2016 | 2.74M | 862.00K | 45.80% |
| Dec 31, 2015 | 1.88M | 321.00K | 20.56% |
| Dec 31, 2014 | 1.56M | -575.68K | -26.94% |
| Dec 31, 2013 | 2.14M | 983.71K | 85.32% |
| Dec 31, 2012 | 1.15M | 131.80K | 12.91% |
| Dec 31, 2011 | 1.02M | -8.96M | -89.77% |
| Dec 31, 2010 | 9.98M | 8.67M | 664.35% |
| Dec 31, 2009 | 1.31M | 456.21K | 53.70% |
| Dec 31, 2008 | 849.49K | 583.89K | 219.85% |
| Dec 31, 2007 | 265.59K | 197.12K | 287.90% |
| Dec 31, 2006 | 68.47K | 52.27K | 322.65% |
| Dec 31, 2005 | 16.20K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 45.77B |
| GSK plc | 32.78B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Surgical Innovations Group | 11.60M |
| GENinCode | 3.08M |
| Verici Dx | 2.72M |
| Oxford BioDynamics | 1.20M |
Proteome Sciences News
- 20 days ago - AIM Market Roundup: Proteome Sciences, Empyrean Energy, Insig AI - The Armchair Trader